Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with rheumatoid arthritis (RA) according to a standard medical scoring system that looks at which joints are affected, certain blood test results, signs of inflammation, and how long symptoms have lasted (a score of at least 6 out of 10 is required — confirm details with trial site)
- People whose RA has been stable for the past three months, meaning their disease activity score (called RAPID-3) has stayed at 4 or below, or their RA medications have not changed in at least six months
- People whose main home is in the North Country region of New York State, specifically in Jefferson, Lewis, St. Lawrence, Clinton, Essex, Franklin, or Hamilton counties
- People who are already established patients at both a participating rheumatology clinic and a participating primary care clinic, with at least one visit to each in the past year
- People who are willing to take part in the study and sign a consent form
- Women who could become pregnant must agree to use highly effective contraception for the entire duration of the study
Who may not be able to join:
- People whose RA treatment has changed in the six months before screening
- People who have a history of interstitial lung disease (a type of lung condition) or any signs of rheumatoid vasculitis, which can affect the skin, nerves, or eyes
- People who have cognitive difficulties or are otherwise unable to complete the study assessments
- People who are currently pregnant, breastfeeding, or planning to become pregnant during the study
- People who would be unable to follow the study's requirements and attend follow-up appointments
- People with other health conditions that the trial doctor considers would make participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eyal Kedar, MD, St. Lawrence Health
Phone: 315-261-6352
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Disease Activity Score (DAS-28)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.